Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

263 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hypoglycemia.
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee; Clayton D, Woo V, Yale JF. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, et al. Among authors: woo v. Can J Diabetes. 2013 Apr;37 Suppl 1:S69-71. doi: 10.1016/j.jcjd.2013.01.022. Epub 2013 Mar 26. Can J Diabetes. 2013. PMID: 24070966 No abstract available.
Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.
DREAM Trial Investigators; Dagenais GR, Gerstein HC, Holman R, Budaj A, Escalante A, Hedner T, Keltai M, Lonn E, McFarlane S, McQueen M, Teo K, Sheridan P, Bosch J, Pogue J, Yusuf S. DREAM Trial Investigators, et al. Diabetes Care. 2008 May;31(5):1007-14. doi: 10.2337/dc07-1868. Epub 2008 Feb 11. Diabetes Care. 2008. PMID: 18268075 Free article. Clinical Trial.
Effects of intensive blood-pressure control in type 2 diabetes mellitus.
ACCORD Study Group; Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, Katz L, Peterson KA, Friedewald WT, Buse JB, Bigger JT, Gerstein HC, Ismail-Beigi F. ACCORD Study Group, et al. N Engl J Med. 2010 Apr 29;362(17):1575-85. doi: 10.1056/NEJMoa1001286. Epub 2010 Mar 14. N Engl J Med. 2010. PMID: 20228401 Free PMC article. Clinical Trial.
Type 2 diabetes mellitus management in Canada: is it improving?
Leiter LA, Berard L, Bowering CK, Cheng AY, Dawson KG, Ekoé JM, Fournier C, Goldin L, Harris SB, Lin P, Ransom T, Tan M, Teoh H, Tsuyuki RT, Whitham D, Woo V, Yale JF, Langer A. Leiter LA, et al. Among authors: woo v. Can J Diabetes. 2013 Apr;37(2):82-9. doi: 10.1016/j.jcjd.2013.02.055. Epub 2013 Apr 23. Can J Diabetes. 2013. PMID: 24070797
Treatment of hypertension.
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee; Gilbert RE, Rabi D, LaRochelle P, Leiter LA, Jones C, Ogilvie R, Tobe S, Khan N, Poirier L, Woo V. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, et al. Among authors: woo v. Can J Diabetes. 2013 Apr;37 Suppl 1:S117-8. doi: 10.1016/j.jcjd.2013.01.033. Epub 2013 Mar 26. Can J Diabetes. 2013. PMID: 24070930 No abstract available.
Monitoring glycemic control.
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee; Berard LD, Blumer I, Houlden R, Miller D, Woo V. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, et al. Among authors: woo v. Can J Diabetes. 2013 Apr;37 Suppl 1:S35-9. doi: 10.1016/j.jcjd.2013.01.017. Epub 2013 Mar 26. Can J Diabetes. 2013. PMID: 24070960 No abstract available.
Pharmacologic management of type 2 diabetes.
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee; Harper W, Clement M, Goldenberg R, Hanna A, Main A, Retnakaran R, Sherifali D, Woo V, Yale JF. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, et al. Among authors: woo v. Can J Diabetes. 2013 Apr;37 Suppl 1:S61-8. doi: 10.1016/j.jcjd.2013.01.021. Epub 2013 Mar 26. Can J Diabetes. 2013. PMID: 24070965 No abstract available.
Influenza and pneumococcal immunization.
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee; Husein N, Woo V. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, et al. Among authors: woo v. Can J Diabetes. 2013 Apr;37 Suppl 1:S93. doi: 10.1016/j.jcjd.2013.01.027. Epub 2013 Mar 26. Can J Diabetes. 2013. PMID: 24070972 No abstract available.
Replacing Insulin Glargine with Neutral Protamine Hagedorn (NPH) Insulin in a Subpopulation of Study Subjects in the Action to Control Cardiovascular Risk in Diabetes (ACCORD): Effects on Blood Glucose Levels, Hypoglycemia and Patient Satisfaction.
Berard L, Cameron B, Woo V, Stewart J. Berard L, et al. Among authors: woo v. Can J Diabetes. 2015 Aug;39(4):296-301. doi: 10.1016/j.jcjd.2014.12.008. Epub 2015 Mar 24. Can J Diabetes. 2015. PMID: 25819531 Clinical Trial.
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group. Green JB, et al. N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. N Engl J Med. 2015. PMID: 26052984 Free article. Clinical Trial.
263 results